{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T07:27:32Z","timestamp":1790148452318,"version":"4.0.1"},"reference-count":49,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Overall, there are over 30 different sexually transmitted infections with <jats:italic toggle=\"yes\">Neisseria gonorrhoeae<\/jats:italic> being the third most frequent with a reported 78 million cases per year. Gonococcal infection causes genital inflammation, which can be a risk factor for others sexually transmitted infections, particularly human immunodeficiency virus. Gonorrhea is a treatable disease, but recently an increase in antibiotic resistance has been of concern. There are currently no vaccines available. However, parenteral vaccination with anti <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic> serogroup B vaccine has been reported to decrease the incidence of gonococcal burden in New Zealand and in Cuba despite the fact that parenteral vaccination is not deemed to induce mucosal IgA. Here we explore possible mechanisms of protection against gonococcal infection through parenteral meningococcal B vaccination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Ninety-two serum, saliva and oropharyngeal swabs samples of young adults (healthy and Neisseria carriers) of the internal higher school were obtained. They have been vaccinated with VA-MENGOC-BC (MBV) during their infancy and boosted with a third dose during this study. Serum and saliva samples were analyzed by ELISA and Western blot to measured IgG and IgA antibodies against <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic> and <jats:italic toggle=\"yes\">N. gonorrhoeae<\/jats:italic> antigens. <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic> carriers were determined by standard microbiologic test. In addition, we reviewed epidemiologic data for <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic> and <jats:italic toggle=\"yes\">N. gonorrhoeae<\/jats:italic> infections in Cuba.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Epidemiologic data show the influence of MBV over gonorrhea incidence suggesting to be dependent of sexual arrival age of vaccines but not over syphilis. Laboratorial data permit the detection of 70 and 22 noncarriers and carriers of <jats:italic toggle=\"yes\">N. meningitidis<\/jats:italic>, respectively. Serum anti-MBV antigens (PL) responses were boosted by a third dose and were independent of carriage stages, but saliva anti-PL IgA responses were only present and were significant induced in carriers subjects. Carriers boosted with a third dose of MBV induced similar antigonococcal and -PL saliva IgA and serum IgG responses; meanwhile, serum antigonococcal IgG was significantly lower. In saliva, at least 2 gonococcal antigens were identified by Western blot. Finally, gonococcal-specific mucosal IgA antibody responses, in addition to the serum IgG antibodies, might contributed to the reduction of the incidence of <jats:italic toggle=\"yes\">N. gonorrhoeae<\/jats:italic>. We hypothesize that this might have contributed to the observed reductions of the incidence of <jats:italic toggle=\"yes\">N. gonorrhoeae<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>These results suggest a mechanism for the influence of a Proteoliposome-based meningococcal BC vaccine on gonococcal incidence.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000003047","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T16:48:31Z","timestamp":1614358111000},"page":"375-381","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":23,"title":["VA-MENGOC-BC Vaccination Induces Serum and Mucosal Anti Neisseria gonorrhoeae Immune Responses and Reduces the Incidence of Gonorrhea"],"prefix":"10.1097","volume":"40","author":[{"given":"Laura M.","family":"Reyes D\u00edaz","sequence":"first","affiliation":[{"name":"Instituto de Ciencias B\u00e1sicas y Precl\u00ednicas \u201cVictoria de Gir\u00f3n,\u201d Havana, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam de S.J.B.","family":"Lastre Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Instituto de Ciencias B\u00e1sicas y Precl\u00ednicas \u201cVictoria de Gir\u00f3n,\u201d Havana, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Cuello","sequence":"additional","affiliation":[{"name":"Facultad de Ingenier\u00edas, Universidad T\u00e9cnica \u201cLuis Vargas Torres\u201d de Esmeraldas, Esmeralda, Ecuador"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V. Gustavo","family":"Sierra-Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"BioCubaFarma, Biotechnological and Pharmaceutical Industries Group of Cuba, Habana, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ramos Pupo","sequence":"additional","affiliation":[{"name":"Immunology Department, Instituto de Ciencias B\u00e1sicas y Precl\u00ednicas \u201cVictoria de Gir\u00f3n,\u201d Havana, Cuba"},{"name":"Biomedical Research Institute (BIOMED), Faculty of Medicine and Life Science, Hasselt University, Hasselt, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Isela","family":"Lantero","sequence":"additional","affiliation":[{"name":"MINSAP, Havana, Cuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M.","family":"Harandi","sequence":"additional","affiliation":[{"name":"Department of Microbiology & Immunology, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden"},{"name":"Vaccine Evaluation Center, British Columbia Children\u2019s Hospital Research Institute, The University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Black","sequence":"additional","affiliation":[{"name":"Cincinnati Children\u2019s Hospital, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"P\u00e9rez","sequence":"additional","affiliation":[{"name":"Instituto de Ciencias B\u00e1sicas y Precl\u00ednicas \u201cVictoria de Gir\u00f3n,\u201d Havana, Cuba"},{"name":"Latin American and Caribean Association of Immunology (ALACI), Havana, Cuba."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,2,9]]},"reference":[{"key":"R2-20250615","doi-asserted-by":"crossref","first-page":"e0143304","DOI":"10.1371\/journal.pone.0143304","article-title":"Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting.","volume":"10","author":"Newman","year":"2015","journal-title":"PLoS One"},{"key":"R5-20250615","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1128\/CMR.00010-14","article-title":"Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.","volume":"27","author":"Unemo","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"R6-20250615","first-page":"1612","volume":"74","author":"Zhu","year":"2006","journal-title":"Comparison of immune responses to gonococcal PorB delivered as outer membrane vesicles, recombinant protein, or Venezuelan equine encephalitis virus replicon particles. Inf Imm"},{"key":"R7-20250615","doi-asserted-by":"crossref","first-page":"7247","DOI":"10.1016\/j.vaccine.2007.07.038","article-title":"Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice.","volume":"25","author":"Price","year":"2007","journal-title":"Vaccine"},{"key":"R8-20250615","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4236\/oji.2020.103005","article-title":"Adjuvant derived from Neisseria meningitidis serogroup B induce cross reactive response against N. gonorrhoeae.","volume":"10","author":"Reyes","year":"2020","journal-title":"Open J Immunol"},{"key":"R9-20250615","doi-asserted-by":"crossref","first-page":"995","DOI":"10.4161\/hv.27739","article-title":"Review of meningococcal vaccines with updates on immunization in adults.","volume":"10","author":"Zahlanie","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"R10-20250615","doi-asserted-by":"crossref","first-page":"4502","DOI":"10.1128\/IAI.69.7.4502-4508.2001","article-title":"Immune response induction and new effector mechanisms possibly involved in protection of Cuban anti-meningococcal BC vaccine.","volume":"69","author":"P\u00e9rez","year":"2001","journal-title":"Infect Immun"},{"key":"R11-20250615","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.vaccine.2004.07.049","article-title":"Interactions of proteoliposomes from serogroup B Neisseria meningitidis with bone marrow-derived dendritic cells and macrophages: adjuvant effects and antigen delivery.","volume":"23","author":"Rodr\u00edguez","year":"2005","journal-title":"Vaccine"},{"key":"R12-20250615","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-3083.2007.01981.x","article-title":"New vaccines require potent adjuvants like AFPL1 and AFCo1.","volume":"66","author":"P\u00e9rez","year":"2007","journal-title":"Scand J Immunol"},{"key":"R13-20250615","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1574-6968.1993.tb06148.x","article-title":"Th2 NH2 terminal (20 aa) of transferring-binding proteins (TBP)1 and TBP2 are cross-reactive between three Neisseria meningitidis and N. gonorrhoeae.","volume":"109","author":"Griffiths","year":"1993","journal-title":"FEMS Microbiol Lett"},{"key":"R14-20250615","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1128\/JB.181.9.2895-2901.1999","article-title":"Ferric enterobactin binding and utilization by Neisseria gonorrhoeae.","volume":"181","author":"Biegel Carson","year":"1999","journal-title":"J Bacteriol"},{"key":"R15-20250615","first-page":"53","article-title":"Mucosal approaches in neisseria vaccinology.","volume":"18","author":"P\u00e9rez","year":"2009","journal-title":"VacciMonitor"},{"key":"R16-20250615","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/infdis\/130.2.160","article-title":"Neisseria gonorrhoeae: effects of systemic immunization on resistance of chimpanzees to urethral infection.","volume":"130","author":"Arko","year":"1974","journal-title":"J Infect Dis"},{"key":"R17-20250615","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1172\/JCI108054","article-title":"Acquired and natural immunity to gonococcal infection in chimpanzees.","volume":"55","author":"Kraus","year":"1975","journal-title":"J Clin Invest"},{"key":"R18-20250615","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.1971.03180360058007","article-title":"Transfer of gonococcal urethritis from man to chimpanzee. An animal model for gonorrhea.","volume":"216","author":"Lucas","year":"1971","journal-title":"JAMA"},{"key":"R19-20250615","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.ijantimicag.2004.06.008","article-title":"Porphyrin-based compounds exert antibacterial action against the sexually transmitted pathogens Neisseria gonorrhoeae and Haemophilus ducreyi.","volume":"24","author":"Bozja","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"R20-20250615","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.1128\/iai.62.9.3957-3961.1994","article-title":"Immunoglobulin G antibodies in human vaginal secretions after parenteral vaccination.","volume":"62","author":"Bouvet","year":"1994","journal-title":"Infect Immun"},{"key":"R21-20250615","doi-asserted-by":"crossref","first-page":"9609","DOI":"10.1128\/JVI.73.11.9609-9613.1999","article-title":"Mucosal but not parenteral immunization with purified human papillomavirus type 16 virus-like particles induce neutralizing titles of antibodies throughout the estrous cycle of mice.","volume":"73","author":"Nardelli-Haefliger","year":"1999","journal-title":"J Virol"},{"key":"R22-20250615","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-2478(01)00263-2","article-title":"Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers.","volume":"79","author":"Broliden","year":"2001","journal-title":"Immunol Lett"},{"key":"R23-20250615","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1128\/iai.39.3.1491-1494.1983","article-title":"Correlation of host immune response with quantitative recovery of Chlamydia trachomatis from the human endocervix.","volume":"39","author":"Brunham","year":"1983","journal-title":"Infect Immun"},{"key":"R24-20250615","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/0264-410X(95)00100-F","article-title":"Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus.","volume":"13","author":"Gallichan","year":"1995","journal-title":"Vaccine"},{"key":"R25-20250615","doi-asserted-by":"crossref","first-page":"5539","DOI":"10.1128\/IAI.68.10.5539-5545.2000","article-title":"Generation of female genital tract antibody responses by local or central (common) mucosal immunization.","volume":"68","author":"Wu","year":"2000","journal-title":"Infect Immun"},{"key":"R26-20250615","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S0264-410X(97)00168-0","article-title":"Induction of mucosal and systemic immune responses by intranasal immunization using recombinant cholera toxin B subunit as an adjuvant.","volume":"16","author":"Wu","year":"1998","journal-title":"Vaccine"},{"key":"R27-20250615","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1128\/iai.65.7.2676-2684.1997","article-title":"Intranasal vaccination of humans with recombinant cholera toxin B subunit induces systemic and local antibody responses in the upper respiratory tract and the vagina.","volume":"65","author":"Bergquist","year":"1997","journal-title":"Infect Immun"},{"key":"R28-20250615","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1128\/IAI.67.6.2884-2890.1999","article-title":"Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit.","volume":"67","author":"Rudin","year":"1999","journal-title":"Infect Immun"},{"key":"R31-20250615","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.vaccine.2009.11.035","article-title":"Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice.","volume":"28","author":"Del Campo","year":"2010","journal-title":"Vaccine"},{"key":"R34-20250615","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1440-1711.2004.01293.x","article-title":"Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern.","volume":"82","author":"P\u00e9rez","year":"2004","journal-title":"Immunol Cell Biol"},{"key":"R35-20250615","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1002\/pmic.200500502","article-title":"Outer membrane vesicles of the VA-MENGOC-BC vaccine against serogroup B of Neisseria meningitidis: analysis of protein components by two-dimensional gel electrophoresis and mass spectrometry.","volume":"6","author":"Uli","year":"2006","journal-title":"Proteomics"},{"key":"R36-20250615","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1002\/pmic.200500821","article-title":"Proteomic analysis of a meningococcal outer membrane vesicle vaccine prepared from the group B strain NZ98\/254.","volume":"6","author":"Vipond","year":"2006","journal-title":"Proteomics"},{"key":"R37-20250615","doi-asserted-by":"crossref","first-page":"347","DOI":"10.4161\/hv.5.5.7367","article-title":"Proteomic study via a non-gel based approach of meningococcal outer membrane vesicle vaccine obtained from strain CU385: a road map for discovering new antigens.","volume":"5","author":"Gil","year":"2009","journal-title":"Hum Vaccin"},{"key":"R38-20250615","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1080\/21645515.2018.1438028","article-title":"Cross-protection induced by VA-MENGOC-BC vaccine.","volume":"4","author":"Ochoa-Azze","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"R39-20250615","first-page":"9","article-title":"Analysis of Neisseria lactamica antigens putatively implicated in acquisition of natural immunity to Neisseria meningitidis","volume":"34","author":"Troncoso","year":"2002","journal-title":"Pathog Dis"},{"key":"R40-20250615","doi-asserted-by":"crossref","first-page":"e11835","DOI":"10.1371\/journal.pone.0011835","article-title":"Genome sequencing reveals widespread virulence gene exchange among human Neisseria species.","volume":"5","author":"Marri","year":"2010","journal-title":"PLoS One"},{"key":"R41-20250615","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fimmu.2019.00683","article-title":"Exploitation of Neisseria meningitidis group B OMV vaccines against N. gonorrhoeae to inform the development and deployment of effective gonorrhea vaccines.","volume":"10","author":"Petousis-Harris","year":"2019","journal-title":"Front Immunol"},{"key":"R42-20250615","first-page":"177","article-title":"Long-lasting cellular immune response in babies, children, and pre-teenagers vaccinated with a proteoliposome based anti-meningococcal BC vaccine.","volume":"20","author":"P\u00e9rez","year":"2001","journal-title":"Inmunolog\u00eda"},{"key":"R43-20250615","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4236\/wjv.2013.32012","article-title":"Proteoliposome and polysaccharide-based meningococcal vaccine are immunogenic in infants and toddlers and primes for memory against serogroup C polysaccharide.","volume":"3","author":"P\u00e9rez","year":"2013","journal-title":"World J Vaccines"},{"key":"R44-20250615","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1128\/JCM.01653-09","article-title":"Clonal distribution of disease-associated and healthy carrier isolates of Neisseria meningitidis between 1983 and 2005 in Cuba.","volume":"48","author":"Climent","year":"2010","journal-title":"J Clin Microbiol"},{"key":"R45-20250615","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.meegid.2010.02.002","article-title":"The genetic structure of Neisseria meningitidis populations in Cuba before and after the introduction of a serogroup BC vaccine.","volume":"10","author":"Climent","year":"2010","journal-title":"Infect Genet Evol"},{"key":"R46-20250615","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1017\/S0950268805004097","article-title":"Influence of age and carriage status on salivary IgA to Neisseria meningitidis.","volume":"133","author":"Horton","year":"2005","journal-title":"Epidemiol Infect"},{"key":"R47-20250615","first-page":"124","article-title":"Characterization of Neisseria meningitidis strains isolated from carriers in Cuba during 20 years.","volume":"58","author":"Mart\u00ednez Motas","year":"2006","journal-title":"Rev Cubana Med Trop"},{"key":"R48-20250615","first-page":"19","article-title":"Cuban meningococcal vaccine VA-MENGOC-BC: 30 years of use and future potential.","volume":"21","author":"Sierra-Gonz\u00e1lez","year":"2019","journal-title":"MEDICC Rev"},{"key":"R49-20250615","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.1128\/IAI.00466-06","article-title":"Comparison and correlation of Neisseria meningitidis serogroup B immunologic assay results and human antibody responses following three doses of the Norwegian meningococcal outer membrane vesicle vaccine MenBvac.","volume":"74","author":"Findlow","year":"2006","journal-title":"Infect Immun"},{"key":"R50-20250615","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1086\/590669","article-title":"Mucosal immunity in healthy adults after parenteral vaccination with outer-membrane vesicles from Neisseria meningitidis serogroup B.","volume":"198","author":"Davenport","year":"2008","journal-title":"J Infect Dis"},{"key":"R51-20250615","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/infdis\/174.6.1223","article-title":"Immunogenicity of Neisseria gonorrhoeae lipooligosaccharide epitope 2C7, widely expressed in vivo with no immunochemical similarity to human glycosphingolipids.","volume":"174","author":"Gulati","year":"1996","journal-title":"J Infect Dis"},{"key":"R52-20250615","doi-asserted-by":"crossref","first-page":"e1003559","DOI":"10.1371\/journal.ppat.1003559","article-title":"Immunization against a saccharide epitope accelerates clearance of experimental gonococcal infection.","volume":"9","author":"Gulati","year":"2013","journal-title":"PLoS Pathog"},{"key":"R53-20250615","first-page":"865","article-title":"Polysaccharides as target of thymus-independent mucosal immune responses and possible cross protection.","author":"Lastre Gonz\u00e1lez","year":"2018","journal-title":"Frontier in Immunology, Immuno Mexico"},{"key":"R54-20250615","first-page":"985","article-title":"Polysaccharides from bacteria and commensals as possible mucosal vaccine and adjuvants.","author":"Reyes D\u00edaz","year":"2018","journal-title":"Frontier in Immunology, Immuno Mexico"},{"key":"R55-20250615","first-page":"75","article-title":"Single time vaccination strategy.","volume":"18","author":"Gonz\u00e1lez","year":"2009","journal-title":"VacciMonitor"},{"key":"R56-20250615","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1139\/cjm-2015-0063","article-title":"Mucosal and systemic immune responses induced by a single time vaccination strategy in mice.","volume":"61","author":"Gonz\u00e1lez Aznar","year":"2015","journal-title":"Can J Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T16:04:21Z","timestamp":1750003461000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000003047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,9]]},"references-count":49,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000003047","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2,9]]}}}